Cellebrite DI Ltd. (CLBT) to Acquire Corellium
Cellebrite DI Ltd. (NASDAQ:CLBT) makes a move to acquire Corellium, a developer of Arm-based virtualization software.
Posts Tagged ‘NASDAQ:CLBT’
Cellebrite DI to Acquire Corellium for $170M
The acquisition is valued at an enterprise value of $170 million in cash, with $20 million converted to equity at closing.
Here are Greenhaven Road Capital’s Views on Cellebrite (CLBT)
Greenhaven Road Capital, an investment management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Cellebrite First Quarter 2025 Financial Results Conference Call.
Greenhaven Road Capital: Cellebrite (CLBT) has a Decade-Long History of Growing Quickly and Profitably
Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q4 2024 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT) Q4 2024 Earnings Call Transcript February 13, 2025Cellebrite DI Ltd. reports earnings inline with expectations.
10 AI News Updates Making Waves on Wall Street
The evolving space of AI has been a major focus these days, as experts and executives are weighing in on how it is reshaping the tech sector.
Amnesty calls out Cellebrite DI (CLBT) for spy tech misuse in Serbia
Cellebrite DI has come under pressure after an allegation that its tech was used for unethical practices in Serbia.
10 Emerging AI Stocks You Should Keep on Your Radar
As reported by CNBC on November 13, OpenAI’s "blueprint for U.S. AI infrastructure" outlines plans for AI economic zones, utilizing the U.S.
Is Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools?
Greenhaven Road Capital, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q3 2024 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT) Q3 2024 Earnings Call Transcript November 6, 2024Cellebrite DI Ltd. beats earnings expectations.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Cellebrite Second Quarter 2024 Financial Results Conference Call.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2024 Earnings Call Transcript
Operator: Welcome to the Cellebrite First Quarter 2024 Financial Results Conference Call.
Should You Hold Cellebrite (CLBT)?
Greenhaven Road Capital, an investment management company, released its first quarter 2024 investor letter. A copy of the same can be downloaded here.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q4 2023 Earnings Call Transcript
Cellebrite DI Ltd. beats earnings expectations. Reported EPS is $0.11, expectations were $0.06. Cellebrite DI Ltd.
Cellebrite (CLBT) Benefitting from Increased Data Volume
Greenhaven Road Capital, an investment management company, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Light Street Capital Returned 46% in 2023: Top 15 Picks
In this piece, we will take a look at Light Street Capital returned 46% in 2023: top 15 picks.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Cellebrite Third Quarter 2023 Financial Results Conference Call. [Operator Instructions].
Should You Hold Cellebrite DI Ltd. (CLBT)?
Greenhaven Road Capital, an investment management company, released its third quarter 2023 investor letter. A copy of the same can be downloaded here.
11 Tech Stocks to Sell Now According to Cathie Wood
In this article, we will take a look at the 11 tech stocks to sell now according to Cathie Wood.
Is Cellebrite DI Ltd. (CLBT) a Good Growth Stock?
Greenhaven Road Capital, an investment management company, released its second quarter 2023 investor letter. A copy of the same can be downloaded here.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Cellebrite's Second Quarter 2023 Financial Results Conference Call.
Should You Invest in Cellebrite DI Ltd. (CLBT)?
Greenhaven Road Capital, an investment management company, released its first quarter 2023 investor letter. A copy of the same can be downloaded here.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Cellebrite's First Quarter 2023 Financial Results Conference Call. At this time, all participants have been placed on a listen-only mode.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Cellebrite's Fourth Quarter 2022 Financial Results Conference Call.
What Makes Cellebrite DI Ltd. (CLBT) an Attractive Stock?
Greenhaven Road Capital, an investment management company, released its fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q3 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Cellebrite Q3 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Is Cellebrite DI Ltd. (CLBT) a Profitable Investment?
Greenhaven Road Capital, an investment management company, released its third-quarter 2022 investor letter. A copy of the same can be downloaded here.
Should You Now Consider Acquiring Cellebrite (CLBT) Shares?
Greenhaven Road Capital, an investment management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here.
Cathie Wood’s Latest Portfolio: 5 New Stock Picks in 2022
In this article we discuss 5 new stock picks of Cathie Wood.
Should You Consider Investing in Cellebrite (CLBT)?
Greenhaven Road Capital, an investment management firm, published its fourth-quarter 2021 investor letter – a copy of which can be downloaded here.
